<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>feed</title>
    <link rel="stylesheet" href="./css/global.css">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Gruppo&display=swap" rel="stylesheet">
</head>

<body class="relative">
    <!-- navbar  -->
    <nav class="bg-gray-800 p-2.5 px-4 md:px-16 shadow sticky top-0 z-[99999] bg-white">
        <div class="container mx-auto flex justify-between items-center">
            <!-- Left Side: Logo -->
            <div class="text-white text-lg font-bold">
                <a href="./index.html"><img src="./public/logo.avif" class="h-10" alt="logo"></a>
            </div>

            <!-- Right Side: Links and Buttons -->
            <div id="desktopNav" class="md:flex space-x-4 items-center text-black text-sm">
                <ul class="flex space-x-4">
                    <li><a href="./index.html" aria-label="Ask">Home</a></li>
                    <!-- <li><a href="./feed.html" aria-label="Feed">Feed</a></li> -->
                    <li><a href="./contact.html" aria-label="About">Contact</a></li>
                    <li><a href="./sponsers.html" aria-label="Announcements">Sponsers</a></li>
                    <li><a href="./signup.html" aria-label="Announcements">Register</a></li>
                </ul>
                <div class="flex gap-x-2 ml-5">
                    <a href="./login.html" class="hover:bg-hover bg-primary text-white px-4 py-2 rounded"
                        aria-label="Sign Up">Login</a>
                </div>
            </div>

            <!-- Hamburger Icon -->
            <button id="navbar-toggle" class="md:hidden text-black focus:outline-none">
                <svg id="navbar-icon" class="w-6 h-5 md:h-6" fill="none" stroke="currentColor" viewBox="0 0 24 24">
                    <path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16m-7 6h7">
                    </path>
                </svg>
            </button>
        </div>

        <!-- Mobile Menu -->
        <div id="navbar" class="hidden md:hidden h-100 flex flex-col space-y-2 mt-2">
            <div class="flex gap-x-2 md:ms-5 w-full my-4 ">
                <a href="login.html"
                    class="w-1/2 text-center hover:bg-slate-100 border bg-slate-50 px-4 py-1.5 rounded">Login</a>
                <a href="./signup.html"
                    class="w-1/2 text-center hover:bg-hover bg-primary text-white px-4 py-1.5 rounded">Sign
                    Up</a>
            </div>
            <a href="./index.html">Home</a>
            <!-- <a href="feed.html">Feed</a> -->
            <a href="./contact.html">Contact</a>
            <a href="./Announcements.html">Sponsers</a>
        </div>
    </nav>



    <section class=" flex justify-center mt-10">
        <div class="container w-full md:w-3/5 rounded-2xl bg-white min-h-screen shadow-sm">
            <div>
                <div class=" border-gray-200 sm:text-sm">
                    <nav class="flex gap-x-1  pt-4" aria-label="Tabs" role="tablist" aria-orientation="horizontal">
                        <button type="button" class="tab-button active w-max flex items-center justify-center" id="tab1"
                            data-tab="tabs-with-icons-1" aria-selected="true">
                            <svg class="MuiSvgIcon-root MuiSvgIcon-fontSizeMedium MuiTab-iconWrapper mui-style-vubbuv mr-2"
                                focusable="false" aria-hidden="true" viewBox="0 0 24 24" data-testid="StarIcon"
                                width="24" height="24">
                                <path
                                    d="M12 17.27 18.18 21l-1.64-7.03L22 9.24l-7.19-.61L12 2 9.19 8.63 2 9.24l5.46 4.73L5.82 21z">
                                </path>
                            </svg>
                            Featured
                        </button>
                        <button type="button" class="tab-button flex items-center justify-center" id="tab2"
                            data-tab="tabs-with-icons-2" aria-selected="false">
                            <svg class="MuiSvgIcon-root MuiSvgIcon-fontSizeMedium MuiTab-iconWrapper mui-style-vubbuv mr-2"
                                focusable="false" aria-hidden="true" viewBox="0 0 24 24" data-testid="TrendingIcon"
                                width="24" height="24">
                                <path d="M3 3h18v2H3zM3 10h12v2H3zM3 17h18v2H3z" />
                            </svg>
                            Trending
                        </button>
                        <button type="button" class="tab-button flex items-center justify-center" id="tab3"
                            data-tab="tabs-with-icons-3" aria-selected="false">
                            <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" width="24" height="24"
                                fill="currentColor" aria-hidden="true">
                                <path d="M3 3h18v18H3V3zm2 2v14h14V5H5zm2 2h10v2H7V7zm0 3h10v2H7v-2zm0 3h10v2H7v-2z" />
                            </svg>

                            New Evidence
                        </button>
                    </nav>
                </div>


                <div class="mt-3">
                    <!-- Featured tab -->
                    <div id="tabs-with-icons-1" role="tabpanel" aria-labelledby="tab1">
                        <div class="container px-8 w-full">
                            <div class="featured">
                                <h3 class="text-4xl font-semibold mt-5 py-3">Featured</h3>
                                <h5 class="text-xl pb-3">Featured by the OpenEvidence team.</h5>
                            </div>
                            <!-- query question-1 -->
                            <div class="mt-5 border-b py-4 border-gray/20">
                                <h3 class="text-lg mb-5">What are health risks associated with GLP-1 receptor agonists
                                    like Ozempic and
                                    Mounjaro?</h3>
                                <div class="flex gap-x-4 relative">
                                    <p class="text-base text-gray">
                                        Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide
                                        (Ozempic) and
                                        tirzepatide
                                        (Mounjaro) are associated with several health risks. The most common adverse
                                        events are
                                        gastrointestinal (GI) in nature, including nausea, vomiting, diarrhea, and
                                        abdominal pain. There
                                        is
                                        also a risk of pancreatitis and biliary disease. Hypersensi...

                                    </p>
                                    <a class="absolute -bottom-0.5 font-semibold text-black/70 text-md right-3 bg-white ps-6 shadow-yellow-50 shadow-2xl"
                                        href="">Read More</a>

                                </div>
                            </div>
                            <!-- query question-2 -->
                            <div class="mt-5 border-b py-4 border-gray/20">
                                <h3 class="text-lg mb-5">What are health risks associated with GLP-1 receptor agonists
                                    like Ozempic and
                                    Mounjaro?</h3>
                                <div class="flex gap-x-4 relative">
                                    <p class="text-base text-gray">
                                        Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide
                                        (Ozempic) and
                                        tirzepatide
                                        (Mounjaro) are associated with several health risks. The most common adverse
                                        events are
                                        gastrointestinal (GI) in nature, including nausea, vomiting, diarrhea, and
                                        abdominal pain. There
                                        is
                                        also a risk of pancreatitis and biliary disease. Hypersensi...

                                    </p>
                                    <a class="absolute -bottom-0.5 font-semibold text-black/70 text-md right-3 bg-white ps-6 shadow-yellow-50 shadow-2xl"
                                        href="">Read More</a>

                                </div>
                            </div>
                            <!-- query question-3 -->
                            <div class="mt-5 border-b py-4 border-gray/20">
                                <h3 class="text-lg mb-5">What are health risks associated with GLP-1 receptor agonists
                                    like Ozempic and
                                    Mounjaro?</h3>
                                <div class="flex gap-x-4 relative">
                                    <p class="text-base text-gray">
                                        Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide
                                        (Ozempic) and
                                        tirzepatide
                                        (Mounjaro) are associated with several health risks. The most common adverse
                                        events are
                                        gastrointestinal (GI) in nature, including nausea, vomiting, diarrhea, and
                                        abdominal pain. There
                                        is
                                        also a risk of pancreatitis and biliary disease. Hypersensi...

                                    </p>
                                    <a class="absolute -bottom-0.5 font-semibold text-black/70 text-md right-3 bg-white ps-6 shadow-yellow-50 shadow-2xl"
                                        href="">Read More</a>

                                </div>
                            </div>
                            <!-- query question-4 -->
                            <div class="mt-5 border-b py-4 border-gray/20">
                                <h3 class="text-lg mb-5">What are health risks associated with GLP-1 receptor agonists
                                    like Ozempic and
                                    Mounjaro?</h3>
                                <div class="flex gap-x-4 relative">
                                    <p class="text-base text-gray">
                                        Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide
                                        (Ozempic) and
                                        tirzepatide
                                        (Mounjaro) are associated with several health risks. The most common adverse
                                        events are
                                        gastrointestinal (GI) in nature, including nausea, vomiting, diarrhea, and
                                        abdominal pain. There
                                        is
                                        also a risk of pancreatitis and biliary disease. Hypersensi...

                                    </p>
                                    <a class="absolute -bottom-0.5 font-semibold text-black/70 text-md right-3 bg-white ps-6 shadow-yellow-50 shadow-2xl"
                                        href="">Read More</a>

                                </div>
                            </div>
                            <!-- query question-5 -->
                            <div class="mt-5 border-b py-4 border-gray/20">
                                <h3 class="text-lg mb-5">What are health risks associated with GLP-1 receptor agonists
                                    like Ozempic and
                                    Mounjaro?</h3>
                                <div class="flex gap-x-4 relative">
                                    <p class="text-base text-gray">
                                        Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide
                                        (Ozempic) and
                                        tirzepatide
                                        (Mounjaro) are associated with several health risks. The most common adverse
                                        events are
                                        gastrointestinal (GI) in nature, including nausea, vomiting, diarrhea, and
                                        abdominal pain. There
                                        is
                                        also a risk of pancreatitis and biliary disease. Hypersensi...

                                    </p>
                                    <a class="absolute -bottom-0.5 font-semibold text-black/70 text-md right-3 bg-white ps-6 shadow-yellow-50 shadow-2xl"
                                        href="">Read More</a>

                                </div>
                            </div>

                            <div class="flex justify-end mt-6 mb-10">
                                <a href="#" class="bg-primary text-white px-3 py-1.5 rounded">See More</a>
                            </div>
                        </div>
                    </div>

                    <!-- Treanding tab -->
                    <div id="tabs-with-icons-2" class="hidden" role="tabpanel" aria-labelledby="tab2">
                        <div class="container px-8 w-full  ">
                            <div class="featured">
                                <h3 class="text-4xl font-semibold mt-5 py-3">Trending Topics</h3>
                                <h5 class="text-xl pb-3">The most asked about topics on OpenEvidence.</h5>
                            </div>

                            <!-- options -->
                            <form class="w-[90%] mx-auto">
                                <label for="specialty-select"
                                    class="block mb-2 text-sm font-medium text-black/80">Specialty</label>
                                <select id="specialty-select"
                                    class="bg-gray-50 border border-gray-300 text-gray-900 text-sm rounded-md focus:ring-primary focus:border-primary block w-full p-2.5">
                                    <option selected value="All Specialties">All Specialties</option>
                                    <option value="Allergy and Immunology">Allergy and Immunology</option>
                                    <option value="Anesthesiology">Anesthesiology</option>
                                    <option value="Cardiology">Cardiology</option>
                                    <option value="Dermatology">Dermatology</option>
                                    <option value="Endocrinology">Endocrinology</option>
                                    <option value="Gastroenterology">Gastroenterology</option>
                                    <option value="Hematology">Hematology</option>
                                    <option value="Infectious Diseases">Infectious Diseases</option>
                                    <option value="Nephrology" selected>Nephrology</option>
                                    <option value="Neurology">Neurology</option>
                                    <option value="Obstetrics & Gynecology (OB/GYN)">Obstetrics & Gynecology (OB/GYN)
                                    </option>
                                    <option value="Oncology">Oncology</option>
                                    <option value="Ophthalmology">Ophthalmology</option>
                                    <option value="Otolaryngology (ENT)">Otolaryngology (ENT)</option>
                                    <option value="Pediatrics">Pediatrics</option>
                                    <option value="Psychiatry">Psychiatry</option>
                                    <option value="Pulmonology">Pulmonology</option>
                                    <option value="Radiology">Radiology</option>
                                    <option value="Rheumatology">Rheumatology</option>
                                    <option value="Urology">Urology</option>
                                </select>
                            </form>

                            <!-- query question-1 -->
                            <div class="mt-5 border-b py-4 border-gray/20">
                                <h3 class="text-lg mb-5">What are health risks associated with GLP-1 receptor agonists
                                    like Ozempic and
                                    Mounjaro?</h3>
                                <div class="flex gap-x-4 relative">
                                    <p class="text-base text-gray">
                                        Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide
                                        (Ozempic) and
                                        tirzepatide
                                        (Mounjaro) are associated with several health risks. The most common adverse
                                        events are
                                        gastrointestinal (GI) in nature, including nausea, vomiting, diarrhea, and
                                        abdominal pain. There
                                        is
                                        also a risk of pancreatitis and biliary disease. Hypersensi...

                                    </p>
                                    <a class="absolute -bottom-0.5 font-semibold text-black/70 text-md right-3 bg-white ps-6 shadow-yellow-50 shadow-2xl"
                                        href="">Read More</a>

                                </div>
                            </div>
                            <!-- query question-2 -->
                            <div class="mt-5 border-b py-4 border-gray/20">
                                <h3 class="text-lg mb-5">What are health risks associated with GLP-1 receptor agonists
                                    like Ozempic and
                                    Mounjaro?</h3>
                                <div class="flex gap-x-4 relative">
                                    <p class="text-base text-gray">
                                        Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide
                                        (Ozempic) and
                                        tirzepatide
                                        (Mounjaro) are associated with several health risks. The most common adverse
                                        events are
                                        gastrointestinal (GI) in nature, including nausea, vomiting, diarrhea, and
                                        abdominal pain. There
                                        is
                                        also a risk of pancreatitis and biliary disease. Hypersensi...

                                    </p>
                                    <a class="absolute -bottom-0.5 font-semibold text-black/70 text-md right-3 bg-white ps-6 shadow-yellow-50 shadow-2xl"
                                        href="">Read More</a>

                                </div>
                            </div>
                            <!-- query question-3 -->
                            <div class="mt-5 border-b py-4 border-gray/20">
                                <h3 class="text-lg mb-5">What are health risks associated with GLP-1 receptor agonists
                                    like Ozempic and
                                    Mounjaro?</h3>
                                <div class="flex gap-x-4 relative">
                                    <p class="text-base text-gray">
                                        Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide
                                        (Ozempic) and
                                        tirzepatide
                                        (Mounjaro) are associated with several health risks. The most common adverse
                                        events are
                                        gastrointestinal (GI) in nature, including nausea, vomiting, diarrhea, and
                                        abdominal pain. There
                                        is
                                        also a risk of pancreatitis and biliary disease. Hypersensi...

                                    </p>
                                    <a class="absolute -bottom-0.5 font-semibold text-black/70 text-md right-3 bg-white ps-6 shadow-yellow-50 shadow-2xl"
                                        href="">Read More</a>

                                </div>
                            </div>

                            <div class="flex justify-end mt-6 mb-10">
                                <a href="#" class="bg-primary text-white px-3 py-1.5 rounded">See More</a>
                            </div>
                        </div>
                    </div>

                    <!-- New Evidence -->
                    <div id="tabs-with-icons-3" class="hidden" role="tabpanel" aria-labelledby="tab3">
                        <div class="container px-8 w-full  ">
                            <div class="featured">
                                <h3 class="text-4xl font-semibold mt-5 py-3">New Evidence</h3>
                                <h5 class="text-xl pb-3">The latest landmark evidence to keep you ahead of the curve.
                                </h5>
                            </div>
                            <!-- options -->
                            <form class="w-[90%] mx-auto">
                                <label for="specialty-select"
                                    class="block mb-2 text-sm font-medium text-black/80">Specialty</label>
                                <select id="specialty-select"
                                    class="bg-gray-50 border border-gray-300 text-gray-900 text-sm rounded-md focus:ring-primary focus:border-primary block w-full p-2.5">
                                    <option selected value="All">All Specialties</option>
                                    <option value="Artificial Intelligence">Artificial Intelligence</option>
                                    <option value="Cardiology">Cardiology</option>
                                    <option value="Endocrinology">Endocrinology</option>
                                    <option value="Gastroenterology">Gastroenterology</option>
                                    <option value="Hepatology">Hepatology</option>
                                    <option value="Infectious Diseases">Infectious Diseases</option>
                                    <option value="Longevity & Wellness">Longevity & Wellness</option>
                                    <option value="Nephrology">Nephrology</option>
                                    <option value="Neurology">Neurology</option>
                                    <option value="Oncology">Oncology</option>
                                    <option value="Pediatrics">Pediatrics</option>
                                    <option value="Rheumatology">Rheumatology</option>
                                </select>
                            </form>



                            <!-- query question-1 -->
                            <div class="mt-5 border-b py-4 border-gray/20">
                                <h3 class="text-lg mb-5">What are health risks associated with GLP-1 receptor agonists
                                    like Ozempic and
                                    Mounjaro?</h3>
                                <div class="flex gap-x-4 relative">
                                    <p class="text-base text-gray">
                                        Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide
                                        (Ozempic) and
                                        tirzepatide
                                        (Mounjaro) are associated with several health risks. The most common adverse
                                        events are
                                        gastrointestinal (GI) in nature, including nausea, vomiting, diarrhea, and
                                        abdominal pain. There
                                        is
                                        also a risk of pancreatitis and biliary disease. Hypersensi...

                                    </p>
                                    <a class="absolute -bottom-0.5 font-semibold text-black/70 text-md right-3 bg-white ps-6 shadow-yellow-50 shadow-2xl"
                                        href="">Read More</a>

                                </div>
                            </div>
                            <!-- query question-2 -->
                            <div class="mt-5 border-b py-4 border-gray/20">
                                <h3 class="text-lg mb-5">What are health risks associated with GLP-1 receptor agonists
                                    like Ozempic and
                                    Mounjaro?</h3>
                                <div class="flex gap-x-4 relative">
                                    <p class="text-base text-gray">
                                        Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide
                                        (Ozempic) and
                                        tirzepatide
                                        (Mounjaro) are associated with several health risks. The most common adverse
                                        events are
                                        gastrointestinal (GI) in nature, including nausea, vomiting, diarrhea, and
                                        abdominal pain. There
                                        is
                                        also a risk of pancreatitis and biliary disease. Hypersensi...

                                    </p>
                                    <a class="absolute -bottom-0.5 font-semibold text-black/70 text-md right-3 bg-white ps-6 shadow-yellow-50 shadow-2xl"
                                        href="">Read More</a>

                                </div>
                            </div>
                            <!-- query question-3 -->
                            <div class="mt-5 border-b py-4 border-gray/20">
                                <h3 class="text-lg mb-5">What are health risks associated with GLP-1 receptor agonists
                                    like Ozempic and
                                    Mounjaro?</h3>
                                <div class="flex gap-x-4 relative">
                                    <p class="text-base text-gray">
                                        Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide
                                        (Ozempic) and
                                        tirzepatide
                                        (Mounjaro) are associated with several health risks. The most common adverse
                                        events are
                                        gastrointestinal (GI) in nature, including nausea, vomiting, diarrhea, and
                                        abdominal pain. There
                                        is
                                        also a risk of pancreatitis and biliary disease. Hypersensi...

                                    </p>
                                    <a class="absolute -bottom-0.5 font-semibold text-black/70 text-md right-3 bg-white ps-6 shadow-yellow-50 shadow-2xl"
                                        href="">Read More</a>

                                </div>
                            </div>

                            <div class="flex justify-end mt-6 mb-10">
                                <a href="#" class="bg-primary text-white px-3 py-1.5 rounded">See More</a>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>


    <!-- top to bottom button -->
    <button id="scrollToTopBtn" class="scrollToTopBtn">
        <svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="#808080"
            stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
            <polyline points="18 15 12 9 6 15" />
        </svg>
    </button>


    <script src="./js/script.js"></script>
</body>

</html>